Evidence map›Paper›PMID 32508051›Full record

ArticleClinical and translational medicine2020

Multidisciplinary therapy strategy of precision medicine in clinical practice.

Mengjia Qian, Qian Li, Miaomiao Zhang, Xiaojing Xu, Qi Shen, Hao Chen, Xiangdong Wang, Tianshu Liu, Yunfeng Cheng

Abstract read
In one paragraph

Article in Clinical and translational medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. New strategies of clinical precision medicine.Clinical and translational medicine · 2022
    Article
  4. Article
  5. Article
  6. Review
  7. How far is single-cell sequencing from clinical application?Clinical and translational medicine · 2020
    Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mengjia QianZhongshan Hospital Institute of Clinical Science, Fudan University Shanghai Medical College, Shanghai, China.
Qian LiDepartment of Oncology, Fudan University, Shanghai Medical College, Shanghai, China.
Miaomiao ZhangZhongshan Hospital Institute of Clinical Science, Fudan University Shanghai Medical College, Shanghai, China.
Xiaojing XuDepartment of Oncology, Fudan University, Shanghai Medical College, Shanghai, China.
Qi ShenZhongshan Hospital Institute of Clinical Science, Fudan University Shanghai Medical College, Shanghai, China.
Hao ChenDepartment of Thoracic Surgery, Zhongshan Hospital Xuhui Branch, Fudan University Shanghai Medical College, Shanghai, China.
Xiangdong WangZhongshan Hospital Institute of Clinical Science, Fudan University Shanghai Medical College, Shanghai, China.
Tianshu LiuDepartment of Oncology, Fudan University, Shanghai Medical College, Shanghai, China.
Yunfeng ChengZhongshan Hospital Institute of Clinical Science, Fudan University Shanghai Medical College, Shanghai, China.ORCID https://orcid.org/0000-0002-9581-1134

Funding

National Natural Science Foundation of China 81870098
6 · The paper itself

Abstract

The application of precision medicine concept in clinical work needs a period of practice and experience accumulation. The present article introduced an example of functioning approach named "multidisciplinary therapy strategy of precision medicine" (MDTS-PM), clinical practice and process, decision-making, and therapies. The MDTS-PM integrates multidisciplinary experts and develops real-time therapeutic strategy based on clinical phenomes and gene sequencing of tissue DNA and circulating DNA. The strength of MDTS-PM is the combination of dynamical clinical phenomes, genetic information, diagnosis, and treatment to make the therapy more targeted and specific. MDTS-PM provides comprehensive, whole-process, and personalized diagnosis and treatment services for patients with complex cancer or complex drug resistance progression; provides guidance for further adjustment of drug use; and establishes a multidisciplinary cooperative team, improves the quality of clinical diagnosis and treatment, and optimizes the process of medical services.

Indexed as

cancergene sequencingMDTS-PMprecision medicinetarget therapy

Identifiers

PMID32508051
PMCPMC7240867

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.